Content related to A Clearer Picture of Inflammatory Bowel Disease (IBD): A Foundation for Newer Treatments

Shedding epithelial cells in the intestine. Image courtesy of Mark R. Frey, PhD, The Saban Research Institute, Children’s Hospital Los Angeles. The lining of the intestine is the most rapidly-renewing

Inflammatory Bowel Disease (IBD) is a debilitating, incurable condition affecting approximately 1.5 million patients in the USA, with annual health care costs of more than $6 billion. The precise

Mark Frey, PhD, an investigator at The Saban Research Institute of Children’s Hospital Los Angeles, studies how the intestines repair themselves after injury.

A clinical trial at Children’s Hospital Los Angeles is the first to study butyrate therapy in Hispanic children with ulcerative colitis.

Inflammatory bowel disease, which includes Crohn’s disease and ulcerative colitis, affects more than 1.4 million Americans and is globally becoming more common. Current medication targets the chronic

Astgik Petrosyan, PhD Astgik is a senior postdoctoral researcher working in Laura Perin ’s laboratory. When asked about where her interest in biology comes from, her answer took us back to the

Early treatment can help overcome this life-threatening condition in premature infants.